Michael Mullan has carried out important medical research in neurodegenerative disorders and is a specialist in various disorders involving the brain, with an emphasis on Alzheimer's disease, as well as in molecular genetics. He has years of experience researching and teaching on the subject of dementia and in working in important medical institutions and centers of research.
Medical Education and Credentials
Michael Mullan holds a Doctorate in Philosophy from the London University, where he studied Molecular Genetics. While at university, he was the recipient of many awards and fellowships due to his contributions to brain research. He was awarded a Travel Fellowship by the American Health Assistance Foundation so that he could join the Second International Conference on Alzheimer's and Related Disorders in Canada. He was given a grant from the Mental Health Foundation to study the amyloid precursor protein locus and its relationship to Alzheimer's disease and he examined the genetic contribution of loci on Chromosome 19 and how it affects early onset of Alzheimer's disease. He was given the 1991 Peacock Senior Fellowship to research the molecular genetic predisposition to neuropsychiatric disorders in London's Institute of Psychiatry and he was the co-principal Investigator at the National Institute of Aging in the study of the early onset of Alzheimer's disease. He was the Principal Investigator of the "Genetics of Schizophrenia" at the Robert Roskamp Private Foundation and a Principal Investigator at the Nancy Driscoll Bequest on the "Genetics of Alcoholism." During his studies at the Royal College of Psychiatrist, he was awarded a Clinical Research Fellowship to study the clinicogenetic correlates existing in Familial Alzheimer's. This research involved training in the major methodologies of the study of molecular genetics, linkage and statistics. He was also given the Bethlem and Maudsley Special Health Authority Research Registrar post by which he studied the clinical and molecular genetics involved with Familial Alzheimer's disease. He graduated with an MRCPsych in 1990 and he also holds an MBBS, which he earned from the London University in 1985.
As Registrar and Senior Registrar of both the Friern Hospital and Royal Free Hospital, Michael Mullan has fulfilled many medical positions. He was in General Adult Psychiatry and Psycho-geriatrics at Friern Hospital and he identified and clinically evaluated familial cases of Alzheimer's disease as a Research Assistant at Middlesex Hospital Medical School. He also worked at the National Hospital for Nervous Diseases, St Mary's Hospital and Bethlem Hospital. From 1994 until 1998 he was the Director at Roskamp Laboratory. He was co-Director of the Alzheimer's Research laboratories, Associate Professor for the Department of Psychiatry at the University of South Florida and the Director of Molecular Genetics Laboratories. He was named Professor in the Division of Psychiatry in 1995, a position that he served until 2003, at which time he became the Chief Executive Officer of the Roskamp Institute in Sarasota, Florida. Additionally, he serves as the CEO at Archer Pharmaceuticals in Florida and is the Director of the Memory Disorder Clinic. At all of his current positions, he continues to search for a long-term cure for Neurodegenerative disorders.